Efficacy of FX Minirail Balloon in Bifurcation Lesions - summitMD.com
Efficacy of FX Minirail Balloon in Bifurcation Lesions - summitMD.com
Efficacy of FX Minirail Balloon in Bifurcation Lesions - summitMD.com
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>Efficacy</strong> <strong>of</strong> <strong>FX</strong> <strong>M<strong>in</strong>irail</strong> <strong>Balloon</strong><br />
<strong>in</strong> <strong>Bifurcation</strong> <strong>Lesions</strong><br />
Junbo Ge, MD, FACC, FESC<br />
Pr<strong>of</strong>essor <strong>of</strong> Medic<strong>in</strong>e/Cardiology<br />
Zhongshan Hospital, Fudan University<br />
Shanghai Institute <strong>of</strong> cardiovascular Diseases<br />
Shanghai, Ch<strong>in</strong>a
PCI <strong>in</strong> bifurcation lesions<br />
Until recently, PCI <strong>in</strong> bifurcation lesions had<br />
rema<strong>in</strong>ed technically challeng<strong>in</strong>g.<br />
Immediate and mid-term results us<strong>in</strong>g<br />
balloon angioplasty were poor:<br />
Low angiographic success rate (75-85%)<br />
High <strong>in</strong>cidence <strong>of</strong> <strong>com</strong>plication (8-22%)<br />
High restenosis rate (40-65%)
Cypher TM Compared with Bare Metal Stents<br />
Side-Branch<br />
ln-Lesion<br />
Restenosis<br />
Bare Metal Stent<br />
Yamashita<br />
Cypher TM<br />
Stent<br />
SIRIUS <strong>Bifurcation</strong>s
Cutt<strong>in</strong>g <strong>Balloon</strong>
QCA Analysis (Basel<strong>in</strong>e)<br />
(mm)<br />
3<br />
2.76<br />
2.66<br />
POBA<br />
CB<br />
2<br />
0.93 0.95<br />
1<br />
0<br />
Reference Diameter<br />
MLD
QCA Analysis (Basel<strong>in</strong>e)<br />
30<br />
20<br />
18.7<br />
20.9<br />
10<br />
0<br />
Lesion Length
QCA Analysis (Post Procedure)<br />
2.5<br />
2.24<br />
*<br />
2.07<br />
POBA<br />
CB<br />
2<br />
1.5<br />
1.28<br />
*<br />
1.12<br />
1<br />
0.5<br />
0<br />
MLD<br />
Acute Ga<strong>in</strong><br />
* p
QCA Analysis (Follow-up)<br />
1.5<br />
1.22<br />
*<br />
1.43<br />
POBA<br />
CB<br />
1<br />
0.5<br />
0.9<br />
*<br />
0.67 0.67<br />
0.55<br />
• Follow-up<br />
period:<br />
5.7±2.3 mo.<br />
• Follow-up<br />
Rate: 63.9%<br />
0<br />
MLD<br />
Late Loss<br />
Loss Index<br />
* p
Restenosis & TLR<br />
60<br />
58<br />
*<br />
47<br />
POBA<br />
CB<br />
39<br />
40<br />
*<br />
21<br />
20<br />
0<br />
Restenosis<br />
TLR<br />
* p
Cutt<strong>in</strong>g balloon angioplasty<br />
<strong>in</strong> proximal LAD bifurcation lesion<br />
Case # 1<br />
• Male, 58 yr<br />
• Anterior MI 1 month ago<br />
• Pre-<strong>in</strong>tervention<br />
angiogram
Cutt<strong>in</strong>g balloon angioplasty<br />
<strong>in</strong> proximal LAD bifurcation lesion<br />
Case # 1<br />
• Proximal LAD<br />
• C.B 3.5mm * 8atm
Cutt<strong>in</strong>g balloon angioplasty<br />
<strong>in</strong> proximal LAD bifurcation lesion<br />
Case # 1<br />
• F<strong>in</strong>al result
Cutt<strong>in</strong>g balloon angioplasty<br />
<strong>in</strong> proximal LAD bifurcation lesion<br />
Case # 1
Cutt<strong>in</strong>g balloon angioplasty prior to<br />
stent<strong>in</strong>g <strong>in</strong> bifurcation lesion<br />
Case # 2<br />
• Male, 52 yr<br />
• Exertional ang<strong>in</strong>a<br />
• Pre-<strong>in</strong>tervention<br />
angiogram
Cutt<strong>in</strong>g balloon angioplasty prior to<br />
stent<strong>in</strong>g <strong>in</strong> bifurcation lesion<br />
Case # 2<br />
• Ostial Diag<br />
• C.B 2.75mm * 10atm<br />
• LAD<br />
• C.B 2.75mm * 10atm
Cutt<strong>in</strong>g balloon angioplasty prior to<br />
stent<strong>in</strong>g <strong>in</strong> bifurcation lesion<br />
Case # 2<br />
• LAD stent<strong>in</strong>g<br />
• 3.5mm*18mm stent
Cutt<strong>in</strong>g balloon angioplasty prior to<br />
stent<strong>in</strong>g <strong>in</strong> bifurcation lesion<br />
Case # 2<br />
• F<strong>in</strong>al result
Cutt<strong>in</strong>g balloon angioplasty prior to<br />
stent<strong>in</strong>g <strong>in</strong> bifurcation lesion<br />
Case # 2
<strong>FX</strong> m<strong>in</strong>iRAIL RX PTCA Catheter
<strong>FX</strong> m<strong>in</strong>iRAIL Angioplasty<br />
• <strong>FX</strong> m<strong>in</strong>iRAIL<br />
Catheter: A well-rounded<br />
approach to a cutt<strong>in</strong>g-<br />
edge solution.<br />
• Concentrated stress<br />
creates expansion planes<br />
at low pressures for<br />
controlled dilatation.<br />
• Stress concentration<br />
• Stability<br />
• Pushability
<strong>FX</strong> m<strong>in</strong>iRAIL Angioplasty
<strong>FX</strong> m<strong>in</strong>iRAIL angioplasty <strong>in</strong><br />
proximal LAD bifurcation lesion<br />
Case # 1
<strong>FX</strong> m<strong>in</strong>iRAIL angioplasty <strong>in</strong><br />
proximal LAD bifurcation lesion<br />
Case # 1
<strong>FX</strong> m<strong>in</strong>iRAIL angioplasty <strong>in</strong><br />
proximal LAD bifurcation lesion<br />
Case # 1
m<strong>in</strong>iRAIL angioplasty <strong>in</strong> a<br />
<strong>FX</strong> m<strong>in</strong>iRAIL angioplasty <strong>in</strong> a<br />
diffuse atherosclerotic lesion<br />
Case # 2
m<strong>in</strong>iRAIL angioplasty <strong>in</strong> a<br />
<strong>FX</strong> m<strong>in</strong>iRAIL angioplasty <strong>in</strong> a<br />
diffuse atherosclerotic lesion<br />
Case # 2
m<strong>in</strong>iRAIL angioplasty <strong>in</strong> a<br />
<strong>FX</strong> m<strong>in</strong>iRAIL angioplasty <strong>in</strong> a<br />
diffuse atherosclerotic lesion<br />
Case # 2
<strong>FX</strong> m<strong>in</strong>iRAIL angioplasty <strong>in</strong><br />
Left Ma<strong>in</strong> Lesion<br />
Case # 3
<strong>FX</strong> m<strong>in</strong>iRAIL Angioplasty <strong>in</strong><br />
Left Ma<strong>in</strong> Lesion<br />
Case # 3
Conclusions<br />
• <strong>FX</strong> m<strong>in</strong>irail balloon is effective <strong>in</strong><br />
treatment <strong>of</strong> bifurcation lesions which<br />
causes less plaque shift<strong>in</strong>g.<br />
• In <strong>com</strong>parison to cutt<strong>in</strong>g balloon, <strong>FX</strong><br />
m<strong>in</strong>irail balloon achieves equally results <strong>in</strong><br />
bifurcation lesions.<br />
• Further studies needed <strong>in</strong> the treatment <strong>of</strong><br />
bifurcation lesions to prove the longterm<br />
benefit even <strong>in</strong> the DES era.